Gewählte Publikation:
Harrison, RE; Flanagan, JA; Sankelo, M; Abdalla, SA; Rowell, J; Machado, RD; Elliott, CG; Robbins, IM; Olschewski, H; McLaughlin, V; Gruenig, E; Kermeen, F; Halme, M; Räisänen-Sokolowski, A; Laitinen, T; Morrell, NW; Trembath, RC.
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.
J Med Genet. 2003; 40(12):865-871
Doi: 10.1136/jmg.40.12.865
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
-
Olschewski Horst
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Mutations of the transforming growth factor beta (TGFbeta) receptor components ENDOGLIN and ALK-1 cause the autosomal dominant vascular disorder hereditary haemorrhagic telangiectasia (HHT). Heterozygous mutations of the type II receptor BMPR2 underlie familial primary pulmonary hypertension. OBJECTIVE: To investigate kindreds presenting with both pulmonary hypertension and HHT. METHODS: Probands and families were identified by specialist pulmonary hypertension centres in five countries. DNA sequence analysis of ALK-1, ENDOGLIN, and BMPR2 was undertaken. Cellular localisation was investigated by heterologous overexpression of mutant constructs in both BAEC and HeLa cells. The impact of a novel sequence variant was assessed through comparative analysis and computer modelling. RESULTS: Molecular analysis of 11 probands identified eight missense mutations of ALK-1, one of which was observed in two families. Mutations were located within exons 5 to 10 of the ALK-1 gene. The majority of ALK-1 mutant constructs appeared to be retained within the cell cytoplasm, in the endoplasmic reticulum. A novel GS domain mutation, when overexpressed, reached the cell surface but is predicted to disrupt conformational changes owing to loss of a critical hydrogen bond. Two novel missense mutations were identified in ENDOGLIN. CONCLUSIONS: The association of pulmonary arterial hypertension and HHT identifies an important disease complication and appears most common among subjects with defects in ALK-1 receptor signalling. Future studies should focus on detailed molecular analysis of the common cellular pathways disrupted by mutations of ALK-1 and BMPR2 that cause inherited pulmonary vascular disease.
- Find related publications in this database (using NLM MeSH Indexing)
-
Activin Receptors, Type I - analysis
-
Activin Receptors, Type II - analysis
-
Adolescent - analysis
-
Adult - analysis
-
Aged - analysis
-
Amino Acid Sequence - analysis
-
Antigens, CD - analysis
-
Bone Morphogenetic Protein Receptors, Type II - analysis
-
DNA Mutational Analysis - analysis
-
Endoplasmic Reticulum - chemistry
-
Female - chemistry
-
Genetic Predisposition to Disease - chemistry
-
Humans - chemistry
-
Hypertension, Pulmonary - diagnosis
-
Male - diagnosis
-
Middle Aged - diagnosis
-
Models, Molecular - diagnosis
-
Mutation, Missense - diagnosis
-
Protein-Serine-Threonine Kinases - genetics
-
Receptors, Cell Surface - genetics
-
Structural Homology, Protein - genetics
-
Telangiectasia, Hereditary Hemorrhagic - complications
-
Vascular Cell Adhesion Molecule-1 - genetics